Journal of Natural Medicines

, Volume 67, Issue 3, pp 534–544 | Cite as

Fucoidan prevents depression-like behavior in rats exposed to repeated restraint stress

Original Paper

Abstract

Previous studies have demonstrated that repeated restraint stress in rodents increased depression-like behavior and altered the expression of corticotrophin-releasing factor in the hypothalamus. The current study focused on verifying the impact of fucoidan (FCN) administration on repeated restraint stress-induced behavioral responses using the forced swimming test (FST). Additionally, we examined the effect of FCN on the central noradrenergic system by observing changes in neuronal tyrosine hydroxylase (TH) immunoreactivity and brain-derived neurotrophic factor (BDNF) mRNA expression in the rat brains. Male rats received 10, 20, or 50 mg/kg FCN (i.p.) 30 min before daily exposures to repeated restraint stress (2 h/day) for 14 days. Repeated restraint stress increased immobility in the FST. Daily administration of FCN during the repeated restraint stress period significantly inhibited the stress-induced behavioral deficits in this behavioral test. Administration of FCN also significantly blocked the increase in TH expression in the locus coeruleus and the basolateral nucleus of the amygdala, and the decrease in BDNF mRNA expression in the hippocampus. Taken together, these findings indicate that administration of FCN prior to restraint stress significantly improved helpless behavior in rats, possibly through modulating the central noradrenergic system. Therefore, FCN may be a useful agent for treating complex symptoms of depression disorder.

Keywords

Stress Depression Tyrosine hydroxylase Brain-derived neurotrophic factor Fucoidan 

References

  1. 1.
    Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370:851–858PubMedCrossRefGoogle Scholar
  2. 2.
    Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894–902PubMedCrossRefGoogle Scholar
  3. 3.
    Kang A, Hao H, Zheng X, Liang Y, Xie Y, Xie T, Dai C, Zhao Q, Wu X, Xie L, Wang G (2011) Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy. J Neuroinflammation 8:100–113PubMedCrossRefGoogle Scholar
  4. 4.
    Wong ML, Licinio J (2001) Research and treatment approaches to depression. Nat Rev Neurosci 2:343–351PubMedCrossRefGoogle Scholar
  5. 5.
    Colman I, Ataullahjan A (2010) Life course perspectives on the epidemiology of depression. Can J Psychiatry 55:622–632PubMedGoogle Scholar
  6. 6.
    Uliaszek AA, Zinbarg RE, Mineka S, Craske MG, Sutton JM, Griffith JW, Rose R, Waters A, Hammen C (2010) The role of neuroticism and extraversion in the stress–anxiety and stress–depression relationships. Anxiety Stress Coping 23:363–381PubMedCrossRefGoogle Scholar
  7. 7.
    Anisman H, Matheson K (2005) Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Revs 29:525–546CrossRefGoogle Scholar
  8. 8.
    Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002) Neurobiology of depression. Neuron 34:13–25PubMedCrossRefGoogle Scholar
  9. 9.
    Maccari S, Morley-Fletcher S (2007) Effects of prenatal restraint stress on the hypothalamus–pituitary–adrenal axis and related behavioural and neurobiological alterations. Psychoneuroendocrinology 32:S10–S15 (review)PubMedCrossRefGoogle Scholar
  10. 10.
    Tsigos C, Chrousos GP (2002) Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53:865–871PubMedCrossRefGoogle Scholar
  11. 11.
    McLaughlin KJ, Gomez JL, Baran SE, Conrad CD (2007) The effects of chronic stress on hippocampal morphology and function: an evaluation of chronic restraint paradigms. Brain Res 1161:56–64PubMedCrossRefGoogle Scholar
  12. 12.
    Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S (2002) Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 22:6810–6818PubMedGoogle Scholar
  13. 13.
    Torres IL, Gamaro GD, Vasconcellos AP, Silveira R, Dalmaz C (2002) Effects of chronic restraint stress on feeding behavior and on monoamine levels in different brain structures in rats. Neurochem Res 27:519–525PubMedCrossRefGoogle Scholar
  14. 14.
    Vollmayr B, Faust H, Lewicka S, Henn FA (2001) Brain-derived-neurotrophic-factor (BDNF) stress response in rats bred for learned helplessness. Mol Psychiatry 6:471–474PubMedCrossRefGoogle Scholar
  15. 15.
    Bravo JA, Díaz-Veliz G, Mora S, Ulloa JL, Berthoud VM, Morales P, Arancibia S, Fiedler JL (2009) Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection. Behav Pharmacol 20:273–285PubMedCrossRefGoogle Scholar
  16. 16.
    O’Mahony CM, Clarke G, Gibney S, Dinan TG, Cryan JF (2011) Strain differences in the neurochemical response to chronic restraint stress in the rat: relevance to depression. Pharmacol Biochem Behav 97:690–699PubMedCrossRefGoogle Scholar
  17. 17.
    Sandi C, Merino JJ, Cordero MI, Touyarot K, Venero C (2001) Effects of chronic stress on contextual fear conditioning and the hippocampal expression of the neural cell adhesion molecule, ITS polysialylation and L1. Neuroscience 102:329–339PubMedCrossRefGoogle Scholar
  18. 18.
    Gregus A, Wintink AJ, Davis AC, Kalynchuk LE (2005) Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav Brain Res 156:105–114PubMedCrossRefGoogle Scholar
  19. 19.
    Dazzi L, Seu E, Cherchi G, Biggio G (2005) Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress. Eur Neuropsychopharmacol 15:283–290PubMedCrossRefGoogle Scholar
  20. 20.
    Smith JM (2010) Clinical implications of treating depressed older adults with SSRIs: possible risk of hyponatremia. J Gerontol Nurs 36:22–27PubMedCrossRefGoogle Scholar
  21. 21.
    Liebert R, Gavey N (2009) “There are always two sides to these things”: managing the dilemma of serious adverse effects from SSRIs. Soc Sci Med 68:1882–1891PubMedCrossRefGoogle Scholar
  22. 22.
    Deligiannidis KM, Freeman MP (2010) Complementary and alternative medicine for the treatment of depressive disorders in women. Psychiatr Clin N Am 33:441–463CrossRefGoogle Scholar
  23. 23.
    Cumashi A, Ushakova NA, Preobrazhenskaya ME, D’Incecco A, Piccoli A, Totani L, Tinari N, Morozevich GE, Berman AE, Bilan MI, Usov AI, Ustyuzhanina NE, Grachev AA, Sanderson CJ, Kelly M, Rabinovich GA, Iacobelli S, Nifantiev NE, Consorzio Interuniversitario Nazionale per la Bio-Oncologia, Italy (2007) A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 17:541–552PubMedCrossRefGoogle Scholar
  24. 24.
    Jhamandas JH, Wie MB, Harris K, MacTavish D, Kar S (2005) Fucoidan inhibits cellular and neurotoxic effects of beta amyloid (A beta) in rat cholinergic basal forebrain neurons. Eur J Neurosci 21:2649–2659PubMedCrossRefGoogle Scholar
  25. 25.
    Bojakowski K, Abramczyk P, Bojakowska M, Zwolinska A, Przybylski J, Gaciong Z (2001) Fucoidan improves the renal blood flow in the early stage of renal ischemia/reperfusion injury in the rat. J Physiol Pharmacol 52:137–143PubMedGoogle Scholar
  26. 26.
    Li C, Gao Y, Xing Y, Zhu H, Shen J, Tian J (2011) Fucoidan, a sulfated polysaccharide from brown algae, against myocardial ischemia–reperfusion injury in rats via regulating the inflammation response. Food Chem Toxicol 49:2090–2095PubMedCrossRefGoogle Scholar
  27. 27.
    Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, New YorkGoogle Scholar
  28. 28.
    Chotiwat C, Harris RB (2008) Antagonism of specific corticotropin-releasing factor receptor subtypes selectively modifies weight loss in restrained rats. Am J Physiol Regul Integr Comp Physiol 295:R1762–R1773PubMedCrossRefGoogle Scholar
  29. 29.
    Ling S, Jamali F (2003) Effect of cannulation surgery and restraint stress on the plasma corticosterone concentration in the rat: application of an improved corticosterone HPLC assay. J Pharm Pharm Sci 6:246–251PubMedGoogle Scholar
  30. 30.
    Vieira C, De Lima TC, Carobrez Ade P, Lino-de-Oliveira C (2008) Frequency of climbing behavior as a predictor of altered motor activity in rat forced swimming test. Neurosci Lett 445:170–173PubMedCrossRefGoogle Scholar
  31. 31.
    Cui YQ, Zhang LJ, Zhang T, Luo DZ, Jia YJ, Guo ZX, Zhang QB, Wang X, Wang XM (2010) Inhibitory effect of fucoidan on nitric oxide production in lipopolysaccharide-activated primary microglia. Clin Exp Pharmacol Physiol 37:422–428PubMedCrossRefGoogle Scholar
  32. 32.
    Guo JY, Guo JY, Li CY, Ruan YP, Sun M, Qi XL, Zhao BS, Luo F (2009) Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. Eur J Pharmacol 612:54–60PubMedCrossRefGoogle Scholar
  33. 33.
    Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56PubMedCrossRefGoogle Scholar
  34. 34.
    Loftis JM, Huckans M, Morasco BJ (2010) Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis 37:519–533PubMedCrossRefGoogle Scholar
  35. 35.
    Ale MT, Maruyama H, Tamauchi H, Mikkelsen JD, Meyer AS (2011) Fucoidan from Sargassum sp. and Fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo. Int J Biol Macromol 49:331–336PubMedCrossRefGoogle Scholar
  36. 36.
    Fan JM, Chen XQ, Jin H, Du JZ (2009) Gestational hypoxia alone or combined with restraint sensitizes the hypothalamic–pituitary–adrenal axis and induces anxiety-like behavior in adult male rat offspring. Neuroscience 10:1363–1373CrossRefGoogle Scholar
  37. 37.
    Suvrathan A, Tomar A, Chattarji S (2010) Effects of chronic and acute stress on rat behaviour in the forced-swim test. Stress 13:533–540PubMedGoogle Scholar
  38. 38.
    Cryan JF, Holmes A (2005) The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4:775–790PubMedCrossRefGoogle Scholar
  39. 39.
    Tanaka M, Telegdy G (2008) Involvement of adrenergic and serotonergic receptors in antidepressant-like effect of urocortin 3 in a modified forced swimming test in mice. Brain Res Bull 77:301–305PubMedCrossRefGoogle Scholar
  40. 40.
    Chotiwat C, Kelso EW, Harris RB (2010) The effects of repeated restraint stress on energy balance and behavior of mice with selective deletion of CRF receptors. Stress 13:203–213PubMedCrossRefGoogle Scholar
  41. 41.
    Ströhle A, Holsboer F (2003) Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 3:S207–S214 (review)Google Scholar
  42. 42.
    MacGillivray L, Reynolds KB, Sickand M, Rosebush PI, Mazurek MF (2011) Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra. Synapse 65:1166–1172PubMedCrossRefGoogle Scholar
  43. 43.
    Osterhout CA, Sterling CR, Chikaraishi DM, Tank AW (2005) Induction of tyrosine hydroxylase in the locus coeruleus of transgenic mice in response to stress or nicotine treatment: lack of activation of tyrosine hydroxylase promoter activity. J Neurochem 94:731–741PubMedCrossRefGoogle Scholar
  44. 44.
    Park HJ, Shim HS, Kim H, Kim KS, Lee H, Hahm DH, Shim I (2010) Effects of glycyrrhizae radix on repeated restraint stress-induced neurochemical and behavioral responses. Korean J Physiol Pharmacol 14:371–376PubMedCrossRefGoogle Scholar
  45. 45.
    Oliva JM, Uriguen L, Perez-Rial S, Manzanares J (2005) Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain. Neuropharmacology 49:618–626PubMedCrossRefGoogle Scholar
  46. 46.
    Spasojevic N, Gavrilovic L, Dronjak S (2010) Effects of repeated maprotiline and fluoxetine treatment on gene expression of catecholamine synthesizing enzymes in adrenal medulla of unstressed and stressed rats. Auton Autacoid Pharmacol 30:213–217PubMedCrossRefGoogle Scholar
  47. 47.
    Redmond DE Jr, Huang YH (1982) The primate locus coerleus and effects of clonidine on opiate withdrawal. J Clin Psychiatry 43:25–29PubMedGoogle Scholar
  48. 48.
    Melia KR, Rasmussen RZ, Terwillinger JW, Haycook EJ, Nestler RS (1992) Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase the rat locus coeruleus: effects of chronic stress and drug treatment. J Neurochem 58:494–502PubMedCrossRefGoogle Scholar
  49. 49.
    Sevgi S, Ozek M, Eroglu L (2003) l-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress. Methods Find Exp Clin Pharmacol 28:95–99CrossRefGoogle Scholar
  50. 50.
    Cirulli F, Berry A, Bonsignore LT, Capone F, D’Andrea I, Aloe L, Branchi I, Alleva E (2010) Early life influences on emotional reactivity: evidence that social enrichment has greater effects than handling on anxiety-like behaviors, neuroendocrine responses to stress and central BDNF levels. Neurosci Biobehav Rev 34:808–820 (review)PubMedCrossRefGoogle Scholar
  51. 51.
    Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR, Gordon E, Kemp AH, Williams LM (2009) Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 14:681–695PubMedCrossRefGoogle Scholar
  52. 52.
    Luo D, Zhang Q, Wang H, Cui Y, Sun Z, Yang J, Zheng Y, Jia J, Yu F, Wang X, Wang X (2009) Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Eur J Pharmacol 617:33–40PubMedCrossRefGoogle Scholar
  53. 53.
    Do H, Kang NS, Pyo S, Billiar TR, Sohn EH (2011) Differential regulation by fucoidan of IFN-γ-induced NO production in glial cells and macrophages. J Cell Biochem 111:1337–1345CrossRefGoogle Scholar

Copyright information

© The Japanese Society of Pharmacognosy and Springer Japan 2012

Authors and Affiliations

  1. 1.Acupuncture and Meridian Science Research Center, College of Oriental MedicineKyung Hee UniversitySeoulKorea
  2. 2.The Graduate School of Basic Science of Oriental Medicine, College of Oriental MedicineKyung Hee UniversitySeoulKorea

Personalised recommendations